Jennison Associates’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-55,579
Closed -$2.68M 618
2023
Q3
$2.68M Buy
55,579
+6,346
+13% +$377K ﹤0.01% 434
2023
Q2
$3.36M Hold
49,233
﹤0.01% 433
2023
Q1
$2.39M Sell
49,233
-8
-0% -$423 ﹤0.01% 454
2022
Q4
$2.97M Buy
+49,241
New +$2.88M ﹤0.01% 440
2022
Q3
Sell
-24,016
Closed -$652K 652
2022
Q2
$652K Sell
24,016
-29
-0.1% -$848 ﹤0.01% 572
2022
Q1
$879K Buy
24,045
+5,414
+29% +$195K ﹤0.01% 572
2021
Q4
$920K Buy
18,631
+4,360
+31% +$242K ﹤0.01% 618
2021
Q3
$1.02M Buy
+14,271
New +$886K ﹤0.01% 606
2018
Q1
Sell
-416,031
Closed -$15.6M 693
2017
Q4
$15.6M Buy
416,031
+5,313
+1% +$271K 0.02% 432
2017
Q3
$26.6M Sell
410,718
-1,185
-0.3% -$72.6K 0.03% 363
2017
Q2
$22.3M Buy
411,903
+2,321
+0.6% +$124K 0.02% 395
2017
Q1
$22.9M Hold
409,582
0.02% 409
2016
Q4
$20.1M Buy
409,582
+1,675
+0.4% +$92.4K 0.02% 409
2016
Q3
$24.5M Sell
407,907
-2,210
-0.5% -$119K 0.03% 384
2016
Q2
$14.3M Sell
410,117
-578
-0.1% -$25.2K 0.02% 440
2016
Q1
$16.9M Buy
410,695
+4,018
+1% +$157K 0.02% 424
2015
Q4
$27.7M Buy
406,677
+1,912
+0.5% +$115K 0.03% 381
2015
Q3
$18.4M Buy
404,765
+3,035
+0.8% +$177K 0.02% 445
2015
Q2
$21.2M Sell
401,730
-174,562
-30% -$6.89M 0.02% 452
2015
Q1
$22M Sell
576,292
-124,462
-18% -$3.19M 0.02% 429
2014
Q4
$14.5M Sell
700,754
-89,425
-11% -$1.87M 0.01% 465
2014
Q3
$17.5M Sell
790,179
-84,615
-10% -$1.79M 0.02% 445
2014
Q2
$19.7M Buy
874,794
+104,060
+14% +$2.6M 0.02% 432
2014
Q1
$29.5M Sell
770,734
-63,121
-8% -$2.03M 0.03% 402
2013
Q4
$22.1M Buy
833,855
+341,761
+69% +$8.57M 0.02% 433
2013
Q3
$9.96M Sell
492,094
-8,481
-2% -$150K 0.01% 477
2013
Q2
$6.46M Buy
+500,575
New +$4.66M 0.01% 480

Other funds holding PRTA

Jennison Associates's PRTA Position: Q4 2023 in Review

Jennison Associates sold out of Prothena Corp (PRTA) in Q4 2023, closing a stake of 55,579 shares — an estimated $2.68M sold.

Jennison Associates first reported a position in PRTA in Q2 2013 and held it in 27 quarters. The position peaked at $29.5M in Q1 2014. 187 funds tracked by Wall St. Rank hold PRTA as of Q4 2023.

  • Jennison Associates reported no remaining Prothena Corp position as of Q4 2023 after selling out during the quarter.
  • Jennison Associates sold 55,579 Prothena Corp shares in Q4 2023, an estimated $2.68M.
  • Jennison Associates first reported a position in Prothena Corp in Q2 2013 and held it in 27 quarters.
  • Jennison Associates's Prothena Corp position peaked at $29.5M in Q1 2014.
  • 187 funds tracked by Wall St. Rank held Prothena Corp as of Q4 2023.

Based on Jennison Associates's 13F filing for Q4 2023, filed 1 Feb 2024.